Licofelone

Licofelone is a dual COX/LOX inhibitor drug studied for osteoarthritis, acting as an anti-inflammatory and analgesic by blocking both cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) pathways, potentially reducing the GI side effects of traditional NSAIDs while also showing promise in neurological disorders due to its anti-inflammatory and neuroprotective effects. It aims to relieve pain and inflammation in conditions like arthritis, with studies exploring its use in spinal cord injury, epilepsy, and neuropathic pain. It is grouped under the following drug class(es): Cyclooxygenase‑2 (COX‑2) Inhibitors and Non-Steroidal Anti-Inflammatory Drugs (NSAID). Its therapeutic use is listed as anti-inflammatories. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Licofelona and Licofelonum. Its PubChem CID is 133021.

CAS No 156897-06-2
Molecular Formula C23H22ClNO2
Molecular Weight 379.90 g/mol
Synonyms 2-[2-(4-chlorophenyl)-6,6-dimethyl-1-phenyl-5,7-dihydropyrrolizin-3-yl]acetic acid

Frequently Asked Questions